UBS Group’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,700
Closed -$40K 10313
2021
Q4
$40K Sell
1,700
-10,400
-86% -$241K ﹤0.01% 7111
2021
Q3
$265K Buy
+12,100
New +$294K ﹤0.01% 5118

Other funds holding CLVT

UBS Group's CLVT Position: Q1 2026 in Review

UBS Group increased its Clarivate (CLVT) stake by 170% in Q1 2026, buying an estimated $14.3M and bringing the position to 8,849,083 shares worth $22.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

UBS Group first reported a position in CLVT in Q4 2018 and has held it in 29 quarters since. The position peaked at $45.9M in Q4 2022. 255 funds tracked by Wall St. Rank hold CLVT as of Q1 2026.

  • UBS Group held 8,849,083 shares of Clarivate worth $22.4M as of Q1 2026.
  • UBS Group bought 5,577,162 Clarivate shares in Q1 2026, an estimated $14.3M.
  • Clarivate made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2469 holding.
  • UBS Group first reported a position in Clarivate in Q4 2018 and has held it in 29 quarters since.
  • UBS Group's Clarivate position peaked at $45.9M in Q4 2022.
  • 255 funds tracked by Wall St. Rank held Clarivate as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.